Mr Schnittker succeeds Brian Lenz, who resigned to accept a CFO position with a biotechnology company and will stay on with VioQuest until August 14, 2008 to assist with the transition.
Prior to joining VioQuest Pharmaceuticals, Mr Schnittker served as senior vice president and CFO at Micromet, from October 2006 to December 2007. He received his BA degree in economics and business with a concentration in accounting from Lafayette College and is a certified public accountant licensed in the State of New Jersey.
Michael Becker, president and CEO of VioQuest, said: ” With his extensive experience in financial management for both public and privately held biotechnology and pharmaceutical companies, Chris will be a tremendous asset for VioQuest as we continue to grow our business in the years ahead.
“His background will help us plan and execute the potential partnership and license opportunities that will advance our pipeline of novel drug therapies targeting both the molecular basis of cancer and side effects of treatment.”